US panel backs COVID-19 pill from Merck

A panel of US health advisers has narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorisation of the first drug that Americans could take at home to treat the virus.

Hold tight - we’re checking permissions before loading more content